19P Mortality among EGFR-mutated advanced NSCLC patients after frontline osimertinib treatment: A real-world, US attrition analysis
| Autor: | Girard, N., Leighl, N., Ohe, Y., Kim, T.M., Demirdjian, L., Bourla, A.B., Sultan, A. Abdul, Mahadevia, P., Bauml, J.M., Sabari, J. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology April 2023 18(4) Supplement:S51-S52 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|